ACM
LLY icon

Advent Capital Management’s Eli Lilly LLY Stock Holding History

Advent Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,500
Closed -$2.89M – 238
2025
Q1 		$2.89M Buy
+3,500
New +$2.91M 0.06% 153
2022
Q2 		– Sell
-10,000
Closed -$2.86M – 267
2022
Q1 		$2.86M Hold
10,000
– – 0.05% 199
2021
Q4 		$2.76M Buy
+10,000
New +$2.54M 0.05% 196

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advent Capital Management's LLY Position: Q2 2025 in Review

Advent Capital Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 3,500 shares — an estimated $2.89M sold.

Advent Capital Management first reported a position in LLY in Q4 2021 and held it in 3 quarters. The position peaked at $2.89M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Advent Capital Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Advent Capital Management sold 3,500 Eli Lilly shares in Q2 2025, an estimated $2.89M.
  • Advent Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 3 quarters.
  • Advent Capital Management's Eli Lilly position peaked at $2.89M in Q1 2025.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Advent Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.